按技術、應用、最終用戶和地區分類的藥物基因體學市場

2025 年全球藥物基因體學市場規模估計為 192.4 億美元，預計到 2032 年將達到 422.9 億美元，2025 年至 2032 年的複合年成長率為 11.9%。

市場佔有率。

藥物基因體學是科學的一個分支，分析基因如何影響人類對藥物的反應。其原理是每個人的基因組成都會影響身體的代謝方式和對藥物的反應。隨著基因篩檢和檢測技術的發展，藥物基因體學旨在開發考慮到患者個體基因特徵的個人化藥物配方方法。這使得能夠根據患者的特定需求更有效地選擇藥物，同時減少試驗的組合和副作用。隨著越來越多的醫療保健系統認知到這種方法在最佳化藥物治療結果方面的臨床實用性，全球藥物基因體學市場預計將在未來幾年大幅成長。

市場動態

全球藥物基因體學市場受到副作用增加、個人化醫療需求不斷成長以及伴同性診斷的廣泛採用等因素的推動。此外，製藥公司不斷增加利用藥物基因體學方法開發標靶治療的研發支出也推動了市場的成長。然而，缺乏臨床檢驗和基因檢測標準化，阻礙了其在臨床實踐中的廣泛應用。與基因篩檢相關的資料隱私和道德問題進一步阻礙了市場擴張。將藥物基因組學測試和分析納入藥物臨床測試和監管核准流程是有機會。價格合理的藥物基因體學診斷試劑套件和服務的開發，特別是在滲透率較低的新興市場，也將為市場成長提供途徑。

研究的主要特點

• 本報告對全球藥物基因體學市場進行了詳細分析，並展示了預測期（2025-2032 年）的市場規模（十億美元）和年複合成長率（CAGR%），以 2024 年為基準年。
• 它還強調了各個領域的潛在收益成長機會，並說明了該市場的引人注目的投資提案矩陣。
• 它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
• 它根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數，概述了全球藥物基因體學市場的主要企業。
• 主要企業包括賽默飛世爾科技公司 (Thermo Fisher Scientific Inc.)、羅氏公司 (F. Hoffmann-La Roche Ltd.)、Pharmigene、雅培 (Abbott)、安捷倫科技公司 (Agilent Technologies, Inc.)、QIAGEN、通用電氣醫療集團 (GE HealthCare)、Empire Inc. Myriad Genetics, Inc.、Illumina, Inc.、Macrogen, Inc.、BGI Genomics、Eurofins Scientific、MapMyGenome 和 Invitae Corporation。
• 本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
• 全球藥物基因體學市場迎合了該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
• 相關人員可以透過分析全球藥物基因體學市場所使用的各種策略矩陣來促進決策。

目錄

第1章 調查目的與前提條件

• 研究目標
• 先決條件
• 簡稱

第2章 市場展望

• 報告描述
  • 市場定義和範圍
• 執行摘要
• 一致的機會圖 (COM)

第3章市場動態、法規與趨勢分析

• 市場動態
  • 驅動程式
  • 限制因素
  • 機會
• 影響分析
• 市場趨勢
• 監管情景
• 製造商收益
• 收購和合作場景
• 產品發布/核准
• 資金籌措和投資
• PEST分析
• 波特的分析

第 4 章。

• 整體影響
• 政府舉措
• COVID-19 市場影響

5. 2020 年至 2032 年全球藥物基因體學市場（按技術分類）（十億美元）

• 介紹
• DNA序列分析
• 微陣列
• 聚合酵素鏈鎖反應
• 電泳
• 質譜分析
• 其他

6. 全球藥物基因體學市場，依應用分類，2020-2032 年（十億美元）

• 介紹
• 心血管疾病
• 感染疾病
• 腫瘤學
• 神經系統疾病
• 疼痛管理
• 其他

7. 2020-2032 年全球藥物基因體學市場（按最終用戶分類）（十億美元）

• 介紹
• 醫院和診所
• 研究和學術機構
• 診斷實驗室
• 其他

8. 2020 年至 2032 年全球藥物基因體學市場（按地區分類）（十億美元）

• 介紹
• 北美洲
• 拉丁美洲
• 歐洲
• 亞太地區
• 中東
• 非洲

第9章 競爭格局

• 公司簡介
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd
  • Pharmigene
  • Abbott
  • Agilent Technologies, Inc.
  • QIAGEN
  • GE HealthCare
  • Empire Genomics, Inc.
  • Bio-Rad Laboratories, Inc.
  • Oxford Nanopore Technologies plc.
  • PerkinElmer Inc.
  • Myriad Genetics, Inc.
  • Illumina, Inc.
  • Macrogen, Inc.
  • BGI Genomics
  • Eurofins Scientific
  • MapMyGenome
  • Invitae Corporation

第 10 章 分析師觀點

• 興衰
• 一致的機會地圖

第 11 章 參考文獻與調查方法

• 參考
• 調查方法

Global Pharmacogenomics Market is estimated to be valued at USD 19.24 Bn in 2025 and is expected to reach USD 42.29 Bn by 2032, growing at a compound annual growth rate (CAGR) of 11.9% from 2025 to 2032.

Figure. Pharmacogenomics Market Share (%), By Region 2025

Pharmacogenomics is the branch of science that analyzes how genes affect a person's response to medications. It works on the principle that each person's genetic make-up can influence how their body metabolizes and responds to drugs. With advancements in genetic screening and testing technologies, pharmacogenomics aims to develop personalized prescription approaches that factor in patients' individual genetic profiles. This enables the selection of effective medicines tailored to patients' specific needs while reducing trial-and-error prescribing practices and adverse drug reactions. The global pharmacogenomics market is expected to grow significantly in the coming years as more healthcare systems recognize the clinical utility of this approach in optimizing pharmacotherapy outcomes.

Market Dynamics:

The global pharmacogenomics market is driven by factors such as rising incidences of adverse drug reactions, growing need for personalized medicine, and increasing uptake of companion diagnostics. High research and development expenditures by pharmaceutical companies to develop targeted therapies using pharmacogenomics approaches are also fueling the market growth. However, lack of clinical validation and standardization of genetic tests remains a challenge limiting widespread clinical adoption. Data privacy and ethical concerns related to genetic screening further hamper market expansion. Opportunities lie in incorporating pharmacogenomic testing and profiling into drug trials and regulatory approval processes. Developing affordable pharmacogenetic diagnostic kits and services especially for underpenetrated emerging markets also presents an avenue for market growth.

Key Features of the Study:

• This report provides an in-depth analysis of the global pharmacogenomics market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global pharmacogenomics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this includes Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Pharmigene, Abbott, Agilent Technologies, Inc., QIAGEN, GE HealthCare, Empire Genomics, Inc., Bio-Rad Laboratories, Inc., Oxford Nanopore Technologies plc., PerkinElmer Inc. , Myriad Genetics, Inc., Illumina, Inc., Macrogen, Inc. , BGI Genomics, Eurofins Scientific, MapMyGenome, and Invitae Corporation.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Global pharmacogenomics market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pharmacogenomics market.

Detailed Segmentation-

• By Technology:
  • DNA Sequencing
  • Microarray
  • Polymerase Chain Reaction
  • Electrophoresis
  • Mass Spectrometry
  • Others
• By Application:
  • Cardiovascular Diseases
  • Infectious Diseases
  • Oncology
  • Neurological Diseases
  • Pain Management
  • Others
• By End User:
  • Hospitals & Clinics
  • Research Institutions and Academic Institutes
  • Diagnostic Laboratories
  • Others
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd
  • Pharmigene
  • Abbott
  • Agilent Technologies, Inc.
  • QIAGEN
  • GE HealthCare
  • Empire Genomics, Inc.
  • Bio-Rad Laboratories, Inc.
  • Oxford Nanopore Technologies plc.
  • PerkinElmer Inc.
  • Myriad Genetics, Inc.
  • Illumina, Inc.
  • Macrogen, Inc.
  • BGI Genomics
  • Eurofins Scientific
  • MapMyGenome
  • Invitae Corporation

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Technology
  • Market Snapshot, By Application
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Manufacturer Revenue
• Acquisitions and Partnerships Scenario
• Product Launches/Approvals
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Pharmacogenomics Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Pharmacogenomics Market, By Technology, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• DNA Sequencing
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Microarray
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Polymerase Chain Reaction
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Electrophoresis
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Mass Spectrometry
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Pharmacogenomics Market, By Application, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Cardiovascular Diseases
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Infectious Diseases
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Oncology
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Neurological Diseases
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Pain Management
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Pharmacogenomics Market, By End User, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Hospitals & Clinics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Research Institutions and Academic Institutes
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Diagnostic Laboratories
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Pharmacogenomics Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • U.S.
  • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • GCC
  • Israel
  • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

• Company Profiles
  • Thermo Fisher Scientific Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • F. Hoffmann-La Roche Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Pharmigene
  • Abbott
  • Agilent Technologies, Inc.
  • QIAGEN
  • GE HealthCare
  • Empire Genomics, Inc.
  • Bio-Rad Laboratories, Inc.
  • Oxford Nanopore Technologies plc.
  • PerkinElmer Inc.
  • Myriad Genetics, Inc.
  • Illumina, Inc.
  • Macrogen, Inc.
  • BGI Genomics
  • Eurofins Scientific
  • MapMyGenome
  • Invitae Corporation

10. Analyst View

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact

"